Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

By  

Oncology, Vol. 87, Iss. 3, 2014-07 ,pp. : 167-172

Karger

Access to resources Recommend Favorite

Oxaliplatin/5‐fluorouracil‐based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 334-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3429-3435

John Wiley & Sons Inc

Access to resources Recommend Favorite

UBD and stage II colon cancer's chemotherapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 680-688

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer

By Gelibter Alain J.   Gamucci Teresa   Pollera Camillo F.   Di Costanzo Francesco   Nuzzo Carmen   Gabriele Angela   Signorelli Carlo   Gasperoni Silvia   Ferraresi Virginia   Giannarelli Diana   Cognetti Francesco   Zeuli Massimo  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2117-2123

Informa Healthcare

Access to resources Recommend Favorite